Page 15 of 19 · 436 questions tagged vendor-vetting.
This is my second independent submission on material from the same supplier. I understand the observation; what I do not understand is the mechanism behind it. I have…
The particulars: 97.9% · ecnoglutide · WWB. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
What I am working with: BCH · Nantong Guangyuan Chemical. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
For reference: GGPeps · survodutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like…
Conditions: 95.2% · tirzepatide · ERP. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write down,…
For reference: SSA · semaglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like that…
Details up front: JEEP · retatrutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
What I am working with: Medutest · GL Biochem (Shanghai). I would like help reading this properly rather than being told what conclusion to reach. I have the full…
I have kept every message, invoice and document, which I gather is the useful habit. I can find plenty of assertions about this and almost no reasoning, which is…
Details up front: 98.2% · orforglipron · MKM. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I would rather be corrected now than propagate something wrong. I am…
Concretely: Homopeptide · liraglutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several times…
What I am working with: lot-specific certificate · JEEP. I have read the primary source rather than the summary, which has left me with more questions. I understand…
Setup, so nobody has to ask: 96.4% · cagrilintide · Homopeptide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but…
This is a first order from this supplier, so I have no track record to reason from. This is a procedural question rather than a theoretical one, and I would like the…
The method section is present, which is unusual enough that I want to make use of it. I would like to know the limits of what can be inferred from this. What I am…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I have read the primary source rather than the summary, which has left…
Stated plainly: ERP · a GLP-1 receptor agonist. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
What I am working with: WXT · GL Biochem (Shanghai). Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
What I have: 98.2% · orforglipron · SSA. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Conditions: CPC · liraglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Can anyone…
Conditions: list of related substances · GGPeps. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Setup, so nobody has to ask: dulaglutide · batch certificate. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
The particulars: 96.4% · semaglutide · KP. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…